As of April 19, 2025, Nykode Therapeutics (NYKD.OL) has a market cap of $74.948 million USD. According to our data, Nykode Therapeutics is ranked No.7793 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 19, 2025 | $74.95 M |
-21.01%
|
Dec 30, 2024 | $94.88 M |
-85.77%
|
Dec 29, 2023 | $0.67 B |
-23.90%
|
Dec 30, 2022 | $0.88 B |
-65.15%
|
Dec 30, 2021 | $2.51 B |
7.61%
|
Dec 30, 2020 | $2.34 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() BioNTech
BNTX
|
$23.74 B |
0.000 M
|
![]() Germany
|
![]() Moderna
MRNA
|
$9.56 B |
-0.000 M
|
![]() USA
|
![]() Curevac
CVAC
|
$0.70 B |
0.000 M
|
![]() Germany
|
![]() Inovio Pharmaceuticals
INO
|
$63.81 M |
0.000 M
|
![]() USA
|
![]() Novavax
NVAX
|
$0.97 B |
0.000 M
|
![]() USA
|
![]() Gritstone bio
GRTS
|
$3.80 M |
2.350 M
|
![]() USA
|
![]() Vaxart
VXRT
|
$78.48 M |
0.890 M
|
![]() USA
|
![]() Dynavax Technologies
DVAX
|
$1.28 B |
0.000 M
|
![]() USA
|
![]() Altimmune
ALT
|
$0.35 B |
-0.000 M
|
![]() USA
|
![]() Immunic
IMUX
|
$93.90 M |
-0.000 M
|
![]() USA
|
![]() Agenus
AGEN
|
$52.64 M |
0.000 M
|
![]() USA
|
![]() Adaptimmune Therapeutics
ADAP
|
$61.27 M |
0.051 M
|
![]() UK
|
![]() Vir Biotechnology
VIR
|
$0.75 B |
-0.000 M
|
![]() USA
|
Market Cap | = | NYKD.OL Stock Price | * | NYKD.OL Shares Outstanding |
= | $0.23 | * | 0.33 B | |
= | $74.95 M |